Pfizer Can't Shake Securities Action Over Celebrex Risks
A New York federal judge on Thursday trimmed a long-running securities class action accusing Pfizer Inc. of concealing serious health risks associated with blockbuster painkillers Celebrex and Bextra, but ruled the...To view the full article, register now.
Already a subscriber? Click here to view full article